Sixera Pharma AB
556901-4763ActiveSmall biotech developing first treatment for rare Netherton syndrome.
Översikt
- 1–4
- Anställda
- ≤1t SEK
- Omsättning
- 2012
- Grundat
Nyckelbeslutsfattare
Hans Olivecrona
Chief Medical Officer
Margit Mahlapuu
Chief Scientific Officer, Board member
Torbjörn Egelrud
Board member
Maria Klockare
Clinical Program Director
+5 fler kontakter i Funnelfeedr
Beskrivning
Sixera Pharma is a small biopharmaceutical company established in Stockholm in 2013. The company originated from a project spun out of Swedish Orphan Biovitrum (Sobi) and Arexis. Their core mission is to develop their lead compound, SXR1096, into the first available treatment for Netherton syndrome....
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556901476301
Beslutsfattare
9 kontakter i FunnelfeedrHans Olivecrona
Chief Medical Officer
Margit Mahlapuu
Chief Scientific Officer, Board member
Torbjörn Egelrud
Board member
Maria Klockare
Clinical Program Director
Jean Nordström
Founder
William Gunnarsson
Board member
Maarten de Château
Chief Executive Officer, Board member
Thomas Eldered
Board member
Lennart Hansson
Chairman of the Board
Liknande företag
20 liknande företag i FunnelfeedrOxThera AB
0 anställdaDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
OxThera Intellectual Property AB
0 anställdaDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
AUTHERA AS
5 anställdaDeveloping novel FcRn-targeting biologics for therapeutic applications.
Devyser Diagnostics AB
1–4 anställdaPioneering simple, fast, accurate genetic testing solutions for global laboratories.
Devyser AB
50–99 anställdaPioneering simple, fast, accurate genetic testing solutions for global laboratories.
Utforska mer
Frågor om Sixera Pharma AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo